Steven Gillis

Steven Gillis

Directeur/Bestuurslid bij TAKEDA PHARMACEUTICAL COMPANY LIMITED

Vermogen: 821 664 $ op 31-05-2026

73 jaar
Health Technology
Finance
Commercial Services

Profiel

Steven H.
Gillis
founded Vilya, Inc. in 2022, Immunex Corp.
in 1981, where he worked as Director, Chief Executive & Scientific Officer from 1981 to 1994, and Corixa Corp.
in 1994, where he worked as Chairman & Chief Executive Officer from 1999 to 2005.
Dr. Gillis also currently works at HiberCell, Inc., as Chairman & Chief Executive Officer from 2025, Theraclone Sciences, Inc., as Chairman from 2011, eGenesis, Inc., as Chairman, and various other companies.
Dr. Gillis also formerly worked at Emergent Product Development Seattle, as Executive Chairman, President & CEO from 2009 to 2010, Allozyne, Inc., as Executive Chairman, Viral Logic Systems Technology Corp., as Chairman in 2009, and various other companies.
Dr. Gillis received his doctorate degree in 1978 from Dartmouth College and undergraduate degree in 1975 from Williams College.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
18-03-2026 25.557 ( 0% ) 821 664 $ 31-05-2026

Actieve functies van Steven Gillis

BedrijvenFunctieBegin
TAKEDA PHARMACEUTICAL COMPANY LIMITED Directeur/Bestuurslid 01-01-2019
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Voorzitter -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Steven Gillis

BedrijvenFunctieEinde
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Steven Gillis in detail bekijken

Opleiding van Steven Gillis

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

59

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit59

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Steven Gillis
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU